Lazard Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,809
| Closed | -$214K | – | 2155 |
|
|
2021
Q1 | $214K | Buy |
+1,809
| New | +$214K | ﹤0.01% | 1088 |
|
|
2018
Q3 | – | Sell |
-1,570
| Closed | -$155K | – | 1144 |
|
|
2018
Q2 | $155K | Buy |
+1,570
| New | +$155K | ﹤0.01% | 866 |
|
|
2018
Q1 | – | Sell |
-1,600
| Closed | -$126K | – | 1179 |
|
|
2017
Q4 | $126K | Buy |
+1,600
| New | +$126K | ﹤0.01% | 912 |
|
|
2017
Q3 | – | Sell |
-100
| Closed | -$11K | – | 1085 |
|
|
2017
Q2 | $11K | Hold |
100
| – | – | ﹤0.01% | 920 |
|
|
2017
Q1 | $10K | Sell |
100
-6,977
| -99% | -$698K | ﹤0.01% | 948 |
|
|
2016
Q4 | $760K | Sell |
7,077
-1,623
| -19% | -$174K | ﹤0.01% | 707 |
|
|
2016
Q3 | $1.08M | Buy |
8,700
+900
| +12% | +$112K | ﹤0.01% | 670 |
|
|
2016
Q2 | $829K | Buy |
7,800
+600
| +8% | +$63.8K | ﹤0.01% | 702 |
|
|
2016
Q1 | $824K | Buy |
+7,200
| New | +$824K | ﹤0.01% | 685 |
|
|
2015
Q4 | – | Sell |
-53,800
| Closed | -$4.83M | – | 1178 |
|
|
2015
Q3 | $4.83M | Buy |
+53,800
| New | +$4.83M | 0.01% | 490 |
|